Foresite Capital
Foresite Capital
About
Key facts
- Portfolio companies
- 17
- Stages
- Series ASeries BSeries CSeries D
- Cheque size
- $30M to $230M
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 13 Aug 2026 | Khartis Therapeutics, Inc. | Series B | $50M |
| 8 Jun 2026 | Stepful | Series C | $55M |
| 3 Feb 2026 | Midi Health | Series D | $100M |
| 21 Aug 2025 | Ontic | Series C | $230M |
| 27 Feb 2025 | Tahoe Therapeutics | Series A | $30M |
| 13 Nov 2023 | GeneDx | Undisclosed round | $150M |
| 27 May 2020 | Insitro | Series B | $143M |
| 31 May 2018 | Insitro | Series A | $100M |
Write the first review
Frequently asked
What companies has Foresite Capital invested in?
Foresite Capital has invested in Khartis Therapeutics, Inc., Stepful, Midi Health, Ontic, Tahoe Therapeutics and 12 more.
SEC filings, insider activity, nonprofit links and pay benchmarks for Foresite Capital:
